Hepatic sclerosis
ICD-10 K74.1 is a billable code used to indicate a diagnosis of hepatic sclerosis.
Hepatic sclerosis, also known as hepatic fibrosis, is characterized by the excessive accumulation of extracellular matrix proteins, leading to the scarring of liver tissue. This condition often arises as a consequence of chronic liver diseases, such as hepatitis, alcoholic liver disease, or non-alcoholic fatty liver disease. Clinically, patients may present with symptoms of liver dysfunction, including jaundice, ascites, and portal hypertension, although early stages may be asymptomatic. The liver anatomy involved includes hepatocytes, portal tracts, and the hepatic vasculature, which become progressively altered as fibrosis advances. Disease progression can lead to cirrhosis and ultimately liver failure if not managed appropriately. Diagnostic considerations include imaging studies such as ultrasound, CT, or MRI, and liver biopsy to assess the degree of fibrosis. Non-invasive markers and scoring systems like the Fibrosis-4 (FIB-4) index or the AST to Platelet Ratio Index (APRI) may also assist in evaluating the severity of hepatic sclerosis.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K74.1 specifically covers hepatic sclerosis resulting from chronic liver diseases, including but not limited to hepatitis B and C, alcoholic liver disease, and non-alcoholic fatty liver disease. It is important to document the underlying cause of liver damage.
K74.1 should be used when there is evidence of hepatic sclerosis, particularly when fibrosis is confirmed through biopsy or imaging. It is distinct from K74.0 (simple hepatic fibrosis) and K74.2 (other chronic hepatitis) based on the severity and clinical implications.
Documentation for K74.1 should include a comprehensive clinical history, results from imaging studies, and liver biopsy findings if performed. Additionally, any laboratory results indicating liver function impairment should be included.
